Forschungsprojekte
Ergebnisse pro Seite:
50
2018 - 2021
ZSE-DUO – Duale Lotsenstruktur zur Abklärung unklarer Diagnosen in Zentren für Seltene Erkrankungen- Univ.-Prof. Dr. OliverTüscher
2017 - 2019
Home-based support program for patient with dementia and their primary informal caregiver administered by professionalized nursing staff (DYADEM)- Prof. Dr. AndreasFellgiebel
2017 - 2020
Mutual Influence of Gut Microbiota Composition and Resilience (DRZ A7)- PD Dr. KristinaEndres
2017 - 2018
Single cell-based microbiome analysis for prediction of cognitive decline in Alzheimer‘s disease- PD Dr. KristinaEndres
2017 - 2020
Neurobehavioral mechanisms of stress inoculation - a translational approach- Univ.-Prof. Dr. MarianneMüller,
- Univ.-Prof. Dr. OliverTüscher
2017 - 2020
Decoding the molecular pathways promoting resilience by targeting activated neuronal subpopulatons- Univ.-Prof. Dr. MarianneMüller
2017 - 2018
Decoding the molecular and epigenetic pathways of antidepressants mechanism of action: focus on the hippocampal dentate gyrus as key target region of antidepressants- Univ.-Prof. Dr. MarianneMüller
2016 - 2020
SFB 1193 "Neurobiology of resilience to stress-related mental dysfunction: from understanding mechanisms to promoting preventions" - Longitudinal determination of resilience in humans to identify mechanisms of resilience to modern-life stressors (Z03); Modelling individual differences in response to stress in mice: an approach to identify neurobiological mechanisms underlying resilience (Z02); Neuronal actin dynamics shaping resilience: the role of the novel actin-interacting protein 'downregulated in renal cancer' (DRR1) (A03); Goal pursuit despite emotional distraction: Neural-network mechanisms of emotional interference inhibition and their role for resilience (C04)- Univ.-Prof. Dr. KlausLieb,
- Univ.-Prof. Dr. MarianneMüller,
- Univ.-Prof. Dr. OliverTüscher
2016 - 2020
An Open-Label, Long-Term Safety Study of SD-809 (deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia- Dr. NadineDreimüller
2016 - 2018
A multi-centre, double-blind, parallel-group, randomised controlled study to investigate efficacy, safety and tolerability of orally administered Bl 409306 during a 12-week treatment period compared to donepezil and placebo in patients with cognitive impairment due to Alzheimer's Disease (1289.7)- Univ.-Prof. Dr. OliverTüscher
2016 - 2019
The Independence of Research as a Multilevel Problem: Interdisciplinary and Methodological Challenges- Univ.-Prof. Dr. KlausLieb
2015 - 2017
Interaction of conflicts of interest and deficits in risk-communication: influence on patient counseling and decision making- Univ.-Prof. Dr. KlausLieb,
- Dr. JanaJünger
2015 - 2018
Evidence-based Stepped Care of ADHD in Late adolescence and adulthood (BMBF)- Prof. Dr. WolfgangRetz
2015 - 2018
Cerebral network connectivity to predict cognitive decline in subjects with mild cognitive impairment with cerebral amyloidosis as measured by [18F] flutemetamol. A study to evaluate whether cerebral network connectivity may be used to predict cognitive decline in subjects with mild cognitive impairment and cerebral amyloidosis (CONNECT).- Univ.-Prof. Dr. AndreasFellgiebel
2015 - 2017
Patienten mit Demenzerkrankung in vollstationärer und teilstationärer gerontopsychiatrischer Behandlung: Demographische und klinische Charakteristika- Univ.-Prof. Dr. AndreasFellgiebel
2015 - 2016
Systematischer Review und Metaanalyse zu psychosozialen Interventionen bei selbstverletzendem Verhalten im Jugendalter (BMBF-Systemat.Review) (BMBF)- Univ.-Prof. Dr. KlausLieb
2015 - 2019
Transfer of cognitive training gains in cognitively healthy aging: Mechanisms and Modulators (AGE GAIN)- Univ.-Prof. Dr. AndreasFellgiebel,
- Univ.-Prof. Dr. OliverTüscher
2014 - 2018
ENSAD: The enteric nervous system as a predictor of pathological shifts and therapeutic response in Alzheimer's Disease- PD Dr. KristinaEndres
2013 - 2015
Untersuchungen zum Outcome und den Langzeitfolgen bei TTP-Patienten- Univ.-Prof. Dr. IngeScharrer,
- Dr. TanjaFalter
2013 - 2016
Mainz Resilience Project (MARP) (Stiftung RLP)- Prof. Dr. RaffaelKalisch,
- Prof. Dr. KlausLieb,
- Prof. Dr. RobertNitsch,
- Prof. Dr. FraukeZipp,
- PD Dr. OliverTüscher
2013 - 2015
Stöchiometrie und Assemblierung von GABA(A)Rezeptoren: Bedeutung einzelner alpha-Untereinheiten in einem Pentamerkomplex- Univ.-Prof. Dr. HartmutLüddens,
- ChristianSattler
2013 - 2016
ELSA transfer of knowledge: pharmacological neuroenhancement, TP1 (BMBF)- Univ.-Prof. Dr. KlausLieb
2013 - 2015
Influence of implicit emotional learning on motor inhibition- Dr. AlexandraSebastian,
- Univ.-Prof. Dr. KlausLieb,
- PD Dr. OliverTüscher
2013 - 2015
EEG and simultaneous EEG/fMRT investigation of the spatiotemporal dynamics of neural motor inhibition- Dr. PatrickJung,
- Univ.-Prof. Dr. KlausLieb,
- PD Dr. OliverTüscher
2012 - 2015
Evaluation of treatment strategies in connection with coercive measures in German psychiatric hospitals pursuing different approaches of inpatient care (BMBF)- Univ.-Prof. Dr. KlausLieb,
- Prof. Dr. KlausMann
2012 - 2013
Idenfizierung neuer Modulatoren der alpha-Sekretase-Aktivität (Sutfe 1)- Dr. KristinaEndres
2012 - 2013
"Strukturelle Integrität der weißen Substanz als Surrogat für (Stufe 1)- Univ.-Prof. Dr. AndreasFellgiebel
2011 - 2012
Identifizierung und in vivo Evaluation von ADAM10- und BACE-1-Modulatoren- PD Dr. UlrichSchmitt,
- Dr. KristinaEndres
2011 - 2014
Opioidergic modulation of alcohol action on the dopaminergic reward-system (DFG)- PD Dr. ChristophFehr,
- Univ.-Prof. Dr. MathiasSchreckenberger
2011 - 2012
Identifizierung neuer Modulatoren der alpha-Sekretase-Aktivitäten (Stufe 1)- Dr. KristinaEndres
2010 - 2012
Multimodale Untersuchung der räumlich-zeitlichen Dynamik von Impulskontrolle (MAIFOR-Projekt)- Dr. ArianMobascher
2010 - 2013
Synthese, 18F-Markierung und Evaluierung hochselektiver Liganden des 5-HT2A-Rezeptorsystems für die molekulare Bildgebung mittels der Positronen-Emissions-Tomographie- Univ.-Prof. Dr. HartmutLüddens
2010 - 2013
Change in executive functioning as a marker for therapeutic response to antidepressant treatment of MDD- Dr. StefanieWagner
2009 - 2013
Randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder – the EMC trial. (BMBF)- Univ.-Prof. Dr. KlausLieb,
- PD Dr. AndréTadic,
- Dr. StanislavGorbulev
2009 - 2011
Cognitive Enhancement aus neuropsychiatrischer Sicht im Forschungsverbund- Univ.-Prof. Dr. KlausLieb,
- PD Dr. AndreasFellgiebel
2009 - 2012
Changes of cerebral spinal fluid APPSα levels under oral therapy with acitretin 30 mg daily in patients with mild to moderate Alzheimer’s disease: a multicenter prospective randomised placebo-controlled parallel-group study (Alzheimer’s Disease Acitretin Medication-ADAM)- PD Dr. AndreasFellgiebel,
- TobiasWittig
2009 - 2013
Effekte von Koffein, Methylphenidat, und Modafinil auf die kognitiven Leistungen bei Schachspielern. Eine randomisierte, placebokontrollierte, doppelblinde Phase-I Studie an gesunden Probanden mit intraindividuellem cross-over Design. (“Cognitive Hyper-performance – Effects of Stimulating Substances in chess-players (CHESS)”)- Prof. Dr. KlausLieb,
- Dr. Dr. A.Franke,
- TobiasWittig